Ratzmann K P, Schimke E, Jung K, Pergande M
Center for Diabetes and Metabolic Disorders, Berlin, G.D.R.
J Diabet Complications. 1989 Jul-Sep;3(3):167-71. doi: 10.1016/0891-6632(89)90041-x.
There is evidence that increased excretion of urinary enzymes and low-molecular mass proteins indicate impaired tubular function. The excretion of N-acetyl-beta-D-glucosaminidase (NAG), lysozyme, and ribonuclease in Type I diabetic patients with (n = 19) and without (n = 17) persistent proteinuria (urinary protein excretion greater than 0.5 g/day) was investigated and compared with this excretion in 30 weight- and gender-matched nondiabetic subjects without renal disease. Urinary NAG excretion was significantly higher in diabetic patients with and without persistent proteinuria (1.16 +/- 0.09 and 3.19 +/- 1.2 Umol/L creatinine, respectively) compared to controls (0.37 +/- 0.03 Umol/L creatinine p less than 0.01). In addition, the urinary excretion of lysozyme and ribonuclease was significantly increased in diabetic patients. Urinary NAG was found to correlate positively with albuminuria and proteinuria (r = 0.95 and 0.93, respectively), as well as with ribonuclease and lysozyme (r = 0.93 and 0.60; p less than 0.01) in patients with persistent proteinuria. Furthermore, NAG excretion was significantly related to the duration of diabetes (r = 0.36; p less than 0.05). No relationship existed between urinary NAG and serum creatinine, beta-2-microglobulin, and degree of metabolic control (HbA7). The lysozyme excretion, but not NAG excretion, was significantly related to hypertension in patients with clinical proteinuria. In conclusion, our results suggest a relationship between the development of tubular dysfunction and the impairment of glomerular function in diabetic nephropathy. An increased excretion of NAG and low-molecular mass proteins may indicate early nephropathy
有证据表明,尿酶和低分子量蛋白质排泄增加表明肾小管功能受损。研究了19例有持续性蛋白尿(尿蛋白排泄量大于0.5g/天)和17例无持续性蛋白尿的I型糖尿病患者的N-乙酰-β-D-氨基葡萄糖苷酶(NAG)、溶菌酶和核糖核酸酶的排泄情况,并与30例体重和性别匹配的无肾脏疾病的非糖尿病受试者的排泄情况进行了比较。与对照组(0.37±0.03μmol/L肌酐,p<0.01)相比,有和无持续性蛋白尿的糖尿病患者尿NAG排泄显著更高(分别为1.16±0.09和3.19±1.2μmol/L肌酐)。此外,糖尿病患者尿溶菌酶和核糖核酸酶排泄显著增加。在有持续性蛋白尿的患者中,发现尿NAG与白蛋白尿和蛋白尿呈正相关(r分别为0.95和0.93),也与核糖核酸酶和溶菌酶呈正相关(r分别为0.93和0.60;p<0.01)。此外,NAG排泄与糖尿病病程显著相关(r=0.36;p<0.05)。尿NAG与血清肌酐、β2-微球蛋白及代谢控制程度(糖化血红蛋白)之间无相关性。在有临床蛋白尿的患者中,溶菌酶排泄而非NAG排泄与高血压显著相关。总之,我们的结果提示糖尿病肾病中肾小管功能障碍的发生与肾小球功能损害之间存在关联。NAG和低分子量蛋白质排泄增加可能表明早期肾病